A three-base-pair deletion in the peripherin–RDS gene in one form of retinitis pigmentosa
GJ Farrar, P Kenna, SA Jordan, R Kumar-Singh… - Nature, 1991 - nature.com
THE group of retinopathies termed retinitis pigmentosa (RP) greatly contribute to visual
dysfunction in man with a frequency of roughly 1 in 4,000 (refs 1, 2). We mapped the first …
dysfunction in man with a frequency of roughly 1 in 4,000 (refs 1, 2). We mapped the first …
[HTML][HTML] On the genetics of retinitis pigmentosa and on mutation‐independent approaches to therapeutic intervention
GJ Farrar, PF Kenna, P Humphries - The EMBO journal, 2002 - embopress.org
Retinitis pigmentosa (RP), the group of hereditary conditions involving death of retinal
photoreceptors, represents the most prevalent cause of visual handicap among working …
photoreceptors, represents the most prevalent cause of visual handicap among working …
Retinopathy induced in mice by targeted disruption of the rhodopsin gene
MM Humphries, D Rancourt, GJ Farrar, P Kenna… - Nature …, 1997 - nature.com
Retinitis pigmentosa (RP) represents the most common mendelian degenerative retinopathy
of man, involving death of rod photoreceptors, cone cell degeneration, retinal vessel …
of man, involving death of rod photoreceptors, cone cell degeneration, retinal vessel …
[PDF][PDF] RNA interference–mediated suppression and replacement of human rhodopsin in vivo
…, AS Kiang, P Humphries, PF Kenna, GJ Farrar - The American Journal of …, 2007 - cell.com
Mutational heterogeneity represents a significant barrier to development of therapies for
many dominantly inherited diseases. For example, >100 mutations in the rhodopsin gene (RHO) …
many dominantly inherited diseases. For example, >100 mutations in the rhodopsin gene (RHO) …
Retinal cells integrate into the outer nuclear layer and differentiate into mature photoreceptors after subretinal transplantation into adult mice
…, G Richard, B Petrowitz, P Humphries, GJ Farrar… - Experimental eye …, 2008 - Elsevier
Vision impairment caused by degeneration of photoreceptors, termed retinitis pigmentosa,
is a debilitating condition with no cure presently available. Cell-based therapeutic …
is a debilitating condition with no cure presently available. Cell-based therapeutic …
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of …
Comparative analysis of the transcriptional profiles of approximately 6000 genes in the
retinas of wild-type mice with those carrying a targeted disruption of the rhodopsin gene was …
retinas of wild-type mice with those carrying a targeted disruption of the rhodopsin gene was …
[HTML][HTML] Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa
For dominantly inherited disorders development of gene therapies, targeting the primary
genetic lesion has been impeded by mutational heterogeneity. An example is rhodopsin-linked …
genetic lesion has been impeded by mutational heterogeneity. An example is rhodopsin-linked …
[HTML][HTML] A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement
…, SH Blanton, S Slifer, I Konidari, GJ Farrar… - European journal of …, 2011 - nature.com
Linkage testing using Affymetrix 6.0 SNP Arrays mapped the disease locus in TCD-G, an Irish
family with autosomal dominant retinitis pigmentosa (adRP), to an 8.8 Mb region on 1p31. …
family with autosomal dominant retinitis pigmentosa (adRP), to an 8.8 Mb region on 1p31. …
Autosomal dominant retinitis pigmentosa (ADRP): localization of an ADRP gene to the long arm of chromosome 3
P McWilliam, GJ Farrar, P Kenna, DG Bradley… - Genomics, 1989 - Elsevier
Members of a large pedigree of Irish origin presenting with early onset Type I autosomal
dominant retinitis pigmentosa (ADRP) have been typed for D3S47 (C17), a polymorphic marker …
dominant retinitis pigmentosa (ADRP) have been typed for D3S47 (C17), a polymorphic marker …
[HTML][HTML] Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy
…, T Li, P Humphries, PF Kenna, GJ Farrar - Molecular Therapy, 2009 - cell.com
Mutational heterogeneity represents one of the greatest barriers impeding the progress toward
the clinic of gene therapies for many dominantly inherited disorders. A general strategy of …
the clinic of gene therapies for many dominantly inherited disorders. A general strategy of …
